Department of Immunology

Lindsey Warner

Lindsey Warner, Graduate Student, UW Department of Immunology

Year Joined: 2018
Email: lindswar@uw.edu
UW Box: 358059
Lab: Stetson Lab

Why I chose UW Immunology

My prior mentors trained at UW, so naturally I was interested in the program and knew its impressive track record. Ultimately, I chose UW because the camaraderie and work-life balance among students was important to me. Apart from the science, I had always wanted to live in Seattle and knew this would be a great opportunity.

Activities and Interests

Seattle is artsy, eclectic, full of nature enthusiasts, and caters to many of my interests! I love everything from backpacking and alpine climbing to salsa dancing and gardening. In the winter, I spend most weekends snowboarding! Otherwise, I enjoy the local breweries, the music scene, hockey, and riding my bike around the city.

Advice from me

Keep in mind that applying to grad school is a two-way street. Any program worth your time will reciprocate your efforts. People in our department are always happy to share advice with past, present, and future trainees. Don’t be afraid to reach out!

More about me

Before joining UW, I earned a Master of Science from UC San Diego and worked as a research technician at the La Jolla Institute. My background is in T cell biology, with a special emphasis on thymic epithelial microRNAs and their roles in regulatory T cell development. I was hesitant to branch away from this niche upon joining UW, but in the end made the difficult decision to join Dan Stetson’s lab to study mechanisms of innate immune signaling.
In the Stetson lab we study nucleic acid sensors, which are commonly targeted for triggering immunogenicity in tumors. Our lab recently identified DNA-PK as a sensor for a STING-independent DNA sensing pathway (SIDSP) in humans. My research evaluates the therapeutic potential of triggering the SIDSP in human tumors. Our goal is to uncover fundamental new aspects of the biology of the SIDSP, together with the first pre-clinical evaluation of DNA-PK activation as a novel cancer immunotherapy.
Print Friendly, PDF & EmailPrintFriendly